This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
DuPont Inks Europe Distribution Deal With Endure Walls
by Zacks Equity Research
DuPont (DD) envisions that the collaboration would better suit its customers in Europe.
New Strong Sell Stocks for May 1st
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Celanese (CE) Earnings Beat Estimates in Q1, Revenues Miss
by Zacks Equity Research
Weak demand hurts Celanese's (CE) revenues in Q1. The company suspends its adjusted earnings per share guidance for 2020.
Celanese (CE) Q1 Earnings Top Estimates
by Zacks Equity Research
Celanese (CE) delivered earnings and revenue surprises of 4.57% and -3.45%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Chemical Stock Earnings Due for Next Week: PPG, CE & More
by Anindya Barman
Let's take a look at how these chemical companies are poised ahead of their earnings release.
Celanese (CE) to Post Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Soft demand conditions and turnarounds across a number of plants are likely to have weighed on Celanese's (CE) Q1 performance.
Celanese Closes Elotex Buyout, Boosts VAE Emulsion Business
by Zacks Equity Research
Celanese (CE) plans to incorporate Elotex's product portfolio and manufacturing facilities into its global VAE emulsion business to cater to the global product demand.
Global Chemicals February Output Drops on Coronavirus Crisis
by Anindya Barman
Global chemical production tumbles 2.4% in February on a monthly comparison basis as a result of the effects of the coronavirus outbreak.
Why Should You Keep Celanese (CE) Stock in Your Portfolio?
by Zacks Equity Research
Celanese (CE) gains from investments in high-return projects, acquisitions and productivity actions.
Moving Average Crossover Alert: Celanese
by Zacks Equity Research
Celanese Corporation (CE) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.
Coronavirus, Tariffs Mar Chemical Specialty Industry Outlook
by Anindya Barman
Weak demand and raw material supply disruptions due to coronavirus as well as hefty trade tariffs pose as headwinds to the chemical specialty industry.
The Zacks Analyst Blog Highlights: Celanese, Eastman Chemical, Westlake Chemical and Huntsman
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Celanese, Eastman Chemical, Westlake Chemical and Huntsman
Coronavirus Stings Chemicals as Global Production Tumbles
by Anindya Barman
Global chemical output dropped 1% in January on a monthly comparison basis under the effects of the coronavirus epidemic.
Why Is Celanese (CE) Down 14.9% Since Last Earnings Report?
by Zacks Equity Research
Celanese (CE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Coronavirus Casts a Pall Over Chemical Industry: Here's How
by Anindya Barman
Chemical makers brace for short-term demand shocks and raw material supply disruptions as a result of the deadly outbreak.
Celanese Inks Deal to Buy Elotex, Boosts Acetyls Business
by Zacks Equity Research
Celanese (CE) expects Elotex acquisition to reinforce its global leadership position in the vinyl acetate ethylene emulsions space, and support customers in construction and building materials.
Celanese (CE) Earnings and Revenues Lag Estimates in Q4
by Zacks Equity Research
Weak global demand hurts Celanese's (CE) revenues in Q4. The company does not expect any meaningful improvement in demand conditions in 2020.
Celanese (CE) Lags Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Celanese (CE) delivered earnings and revenue surprises of -4.78% and -4.65%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
3 Chemical Stocks Likely to Outshine Q4 Earnings Estimates
by Anindya Barman
The impact of demand weakness might be reflected on the performance of chemical companies in Q4.
Chemical Stock Earnings Due on Jan 30: DD, CE, EMN & AXTA
by Anindya Barman
Let's take a look at how these chemical companies are poised ahead of their Q4 earnings release.
Celanese (CE) to Post Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Our proven model does not conclusively predict an earnings beat for Celanese (CE) this season.
Analysts Estimate Celanese (CE) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Celanese (CE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Celanese Increases Prices of Acetyl Intermediates Products
by Zacks Equity Research
Celanese's (CE) latest price hike is incremental to any previously announced hikes.
Celanese's Ethylene-based VAM Awarded Green Technology Tag
by Zacks Equity Research
Celanese's (CE) ethylene-based VAM technology awarded "Green Technology" designation due to its low carbon emissions, low content of heavy components, low energy consumption and high product quality.
Celanese (CE) to Raise Acetyl Intermediates Product Price
by Zacks Equity Research
Celanese (CE) expects the price hike to be effective from Jan 1, 2020, or as contracts permit.